Technical Analysis for NNVC - NanoViricides, Inc.

Grade Last Price % Change Price Change
F 1.42 -0.70% -0.01
NNVC closed down 0.7 percent on Friday, November 1, 2024, on 57 percent of normal volume.
Earnings due: Nov 12
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Resistance Bearish -0.70%
Pocket Pivot Bullish Swing Setup -0.70%
Bollinger Band Squeeze Range Contraction -0.70%
Gapped Up Strength -0.70%
20 DMA Resistance Bearish 4.41%
Bollinger Band Squeeze Range Contraction 4.41%
BB Squeeze + Lower Band Touch Range Contraction 4.41%
Lower Bollinger Band Touch Weakness 4.41%
Fell Below 20 DMA Bearish -1.39%

   Recent Intraday Alerts

Alert Time
Down 3% about 20 hours ago
Down 2 % about 20 hours ago
Down 1% about 20 hours ago
Up 1% about 23 hours ago
Rose Above Previous Day's High 2 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NanoViricides, Inc. Description

NanoViricides, Inc. a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, a injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could enable a functional cure for HIV/AIDS; HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; Nanoviricide anti-viral eye drops against external eye viral infections; and DengueCide, a treatment against Dengue viruses. It is also developing RabiCide, an anti-rabies nanoviricide; and Nanoviricide for the treatment of various strains of Ebola and Marburg filoviruses. The company has licenses to develop drugs for the treatment of human viral diseases, such as H5N1 (avian flu), human influenza, human immunodeficiency virus (HIV/AIDS), hepatitis B virus, hepatitis C virus, herpes simplex virus, and rabies; and dengue viruses, Japanese encephalitis virus, West Nile virus, viruses causing viral conjunctivitis and ocular herpes, and Ebola/Marburg viruses, as well as viral diseases of the eye comprising epidemic kerato-conjunctivitis and herpes keratitis. NanoViricides, Inc. was founded in 2005 and is based in West Haven, Connecticut.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Infectious Diseases Eye Infection Influenza Coronavirus Hepatitis B Viruses HIV Hepatitis C Immunodeficiency Hepatitis C Virus Virus Antiviral Drug Hepatitis B Virus Viral Disease HIV/Aids Herpes Ebola Herpes Simplex Rabies Dengue Epidemiology Herpes Simplex Virus Viral Infections Genital Herpes Viral Conjunctivitis Viral Infection

Is NNVC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.59
52 Week Low 1.0
Average Volume 173,956
200-Day Moving Average 1.61
50-Day Moving Average 1.56
20-Day Moving Average 1.45
10-Day Moving Average 1.46
Average True Range 0.10
RSI (14) 44.75
ADX 10.39
+DI 14.34
-DI 21.32
Chandelier Exit (Long, 3 ATRs) 1.25
Chandelier Exit (Short, 3 ATRs) 1.60
Upper Bollinger Bands 1.55
Lower Bollinger Band 1.35
Percent B (%b) 0.34
BandWidth 13.90
MACD Line -0.03
MACD Signal Line -0.03
MACD Histogram 0.0026
Fundamentals Value
Market Cap 16.68 Million
Num Shares 11.7 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -1.84
Price-to-Sales 0.00
Price-to-Book 1.03
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.52
Resistance 3 (R3) 1.52 1.49 1.51
Resistance 2 (R2) 1.49 1.46 1.49 1.50
Resistance 1 (R1) 1.45 1.44 1.43 1.45 1.50
Pivot Point 1.42 1.42 1.41 1.42 1.42
Support 1 (S1) 1.38 1.39 1.37 1.39 1.34
Support 2 (S2) 1.35 1.37 1.35 1.34
Support 3 (S3) 1.31 1.35 1.33
Support 4 (S4) 1.32